Moreover, CXCL12 supports MM growth through the induction of interleukin-6 (IL-6) and vascular endothelial growth factor (VEGF) secretion and increases invasion and matrix metalloproteinase (MMP) secretion in myeloma PCs [32, 43]. Here, IL6 is linked to plasma cell myeloma.